Closing Bell: Nifty ends May series near 11,950, Sensex up 329 points; NTPC gains 3%

It is strong close for the May F&O series on Thursday with Nifty finished near 11,950 level.

At close, the Sensex was up 329.92 points at 39,831.97, while Nifty was up 84.80 points at 11,945.90. About 1236 shares have advanced, 1301 shares declined, and 153 shares are unchanged.

NTPC, Yes Bank, Bharti Airtel, Bajaj Finance and BPCL were among major gainers on the Nifty, while losers were Sun Pharma, M&M, Zee Entertainment, Eicher Motors and JSW Steel.

Among the sectors, auto, pharma and metal ended lower, while buying seen in the infra, IT, PSU bank and energy.

: Profit up 4.9 percent at Rs 111.4 crore, compared to Rs 106.2 crore in the corresponding quarter of last fiscal. Revenue rises 13.4 percent at Rs 1,472 crore versus Rs 1,298.3 crore in the year-ago period.

World Cup portfolio: IIFL picks winning combo of 11 'players' for investors

Marking the day when Modi takes oath for the second term and the start of the World Cup, IIFL has selected 11 stocks or the Dream Team portfolio for investors that could reap runs until the next general elections... Read More

Net profit rose 28.6% at Rs 76.7 crore against Rs 59.6 crore and revenue up 16.3% at Rs 2,167.1 crore against Rs 1,863.4 crore.
EBITDA was up 24.2% at Rs 266 crore against Rs 214 crore, margin was at 12.3% versus 11.5%.

: Net profit down 17.9% at Rs 35.4 crore against Rs 43.1 crore, revenue up at Rs 605.7 crore against Rs 541.9 crore, YoY.

D-Street Buzz: TCS, Bharti Airtel jump 2% each; RIL most active, autos drag

The breadth of the market favoured the declines as 800 stocks advanced and 910 declined while 388 remained unchanged on the NSE. On the BSE, 1130 stocks advanced, 1306 declined and 148 remained unchanged.... Read More

Consolidated net profit was up at Rs 167.3 crore against Rs 67.1 crore, revenue was up 24.3% at Rs 1,854.2 crore versus Rs 1,492 crore, YoY.

The company has reached a settlement agreement with Onyx Therapeutics, Inc. on patent litigation related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

Net profit was down 11% at Rs 22 crore versus Rs 24.7 crore, revenue was down at Rs 75.3 crore versus Rs 76.5 crore.

Operating profit or EBITDA down 29.9% at Rs 36.7 crore and margin was at 48.7 percent.

: The Indian rupee is trading flat at 69.84 per dollar versus previous close 69.83.

Net loss at Rs 1.1 crore against loss of Rs 2.4 crore, revenue down 1% at Rs 40.3 crore versus Rs 40.7 crore, YoY.

Vaibhav Global approved a proposal to buyback its own fully paid-up equity shares of face value of Rs 10 from the equity shareholders of the company for a price not exceeding Rs 1,000 per equity share.